Triazines with suitable spacers for treatment and/or prevention of HIV infections

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9650348
SERIAL NO

14385843

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the field of HIV-1 infections, and in particular provides novel compounds containing triazine rings and suitable spacers. The compounds according to this invention are very suitable for the prevention and/or treatment of HIV-1 infection and in particular show improved activity against NNRTI-resistant viruses of HIV-1.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INSTITUUT VOOR TROPISCHE GENEESKUNDENATIONALESTRAAT 155 ANTWERPEN 2000

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Arien, Kevin Karel Florentina Antwerpen, BE 5 2
Augustyns, Koen Wilrijk, BE 12 22
Heeres, Jan Vosselaar, BE 121 1484
Joossens, Jurgen Zoersel, BE 10 20
Lewi, Paulus - 1 0
Muthusamy, Venkatraj Wilrijk, BE 2 0
Van, Der Veken Pieter Sint-Katelijne Waver, BE 13 25
Vanham, Guido Louis Emile Antwerpen, BE 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 16, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00